Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
British Medical Bulletin|September 6, 2014
Management of melanomaPippa Corrie, Mirela Hategan, Kate Fife, et al.The Lancet. Oncology|October 5, 2015
Evolving treatment options for melanoma brain metastasesThankamma Ajithkumar, Christine Parkinson, Kate Fife, et al.Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 7, 2011
The International Core Literature Consensus (ICLC): an alternative curriculum for OncologistsShilpen Patel, Reshma Jagsi, Natalie Cook, et al.Plos One|May 10, 2014
Conditions associated with circulating tumor-associated folate receptor 1 protein in healthy men and womenLinda E Kelemen, James D Brenton, Christine Parkinson, et al.Anti-Cancer Drugs|November 18, 2015
Intensive cisplatin/oral etoposide for epithelial ovarian cancer: the Cambridge Gynae-Oncology Centre experience: too toxic for relapse?Ioannis Gounaris, Mahesh Iddawela, Christine Parkinson, et al.Gynecologic Oncology Case Reports|December 28, 2013
Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutationHan Hsi Wong, Christine Parkinson, Jonathan A Ledermann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volumeAndrea G Rockall, Norbert Avril, Raymond Lam, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 12, 2015
Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution StudyKaren Sayal, Ioannis Gounaris, Bristi Basu, et al.Science Translational Medicine|June 1, 2012
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNATim Forshew, Muhammed Murtaza, Christine Parkinson, et al.British Journal of Cancer|October 7, 2020
The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrenceRoy Rabbie, Peter Ferguson, Kim Wong, et al.Pageof 3